| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.009 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.083 | 0.009 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |